BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21483822)

  • 1. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies.
    Chu H; Wang M; Shi D; Ma L; Zhang Z; Tong N; Huo X; Wang W; Luo D; Gao Y; Zhang Z
    PLoS One; 2011 Mar; 6(3):e18108. PubMed ID: 21483822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk.
    Yuan Z; Zeng X; Yang D; Wang W; Liu Z
    PLoS One; 2013; 8(4):e61047. PubMed ID: 23593385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case-control studies.
    Wang Y; Yang B; Ren X
    Gene; 2012 Nov; 509(2):267-72. PubMed ID: 22922391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children.
    Tong N; Xu B; Shi D; Du M; Li X; Sheng X; Wang M; Chu H; Fang Y; Li J; Wu D; Zhang Z
    Mutat Res; 2014 Jan; 759():16-21. PubMed ID: 24291415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of single nucleotide polymorphisms in miR-146a and miR-196a2 on the prevalence of cancer in elderly Japanese: a case-control study.
    Parlayan C; Ikeda S; Sato N; Sawabe M; Muramatsu M; Arai T
    Asian Pac J Cancer Prev; 2014; 15(5):2101-7. PubMed ID: 24716941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.
    Wei J; Zheng L; Liu S; Yin J; Wang L; Wang X; Shi Y; Shao A; Tang W; Ding G; Liu C; Chen S; Gu H
    Hum Immunol; 2013 Sep; 74(9):1199-205. PubMed ID: 23792053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis.
    Wang F; Ma YL; Zhang P; Yang JJ; Chen HQ; Liu ZH; Peng JY; Zhou YK; Qin HL
    Mol Biol Rep; 2012 Jan; 39(1):269-75. PubMed ID: 21625865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies.
    Guo J; Jin M; Zhang M; Chen K
    PLoS One; 2012; 7(1):e30585. PubMed ID: 22291993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-RNA 196a2 expression and miR-196a2 (rs11614913) polymorphism in T1DM: a pilot study.
    Ibrahim AA; Ramadan A; Wahby AA; Hassan M; Soliman HM; Abdel Hamid TA
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1171-1179. PubMed ID: 31472066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45,816 subjects.
    Kang Z; Li Y; He X; Jiu T; Wei J; Tian F; Gu C
    Tumour Biol; 2014 Jul; 35(7):6271-82. PubMed ID: 24633889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.
    Xu W; Xu J; Liu S; Chen B; Wang X; Li Y; Qian Y; Zhao W; Wu J
    PLoS One; 2011; 6(5):e20471. PubMed ID: 21637771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between rs11614913 polymorphism in miR-196a2 and colorectal cancer risk: a meta-analysis.
    Du W; Ma X; Kong W; Liu T; Wei B; Yu J; Li Y; Huang J; Li Z; Liu L
    Cancer Biomark; 2013 Jan; 13(6):457-64. PubMed ID: 24595083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and gastrointestinal cancer risk.
    Wang F; Sun GP; Zou YF; Fan LL; Song B
    Mol Biol Rep; 2013 Jan; 40(1):109-16. PubMed ID: 23160898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk.
    Srivastava K; Srivastava A
    PLoS One; 2012; 7(11):e50966. PubMed ID: 23226435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
    Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
    Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of Hsa-mir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies.
    Chen C; Yang S; Chaugai S; Wang Y; Wang DW
    BMC Med Genet; 2014 Nov; 15():126. PubMed ID: 25433484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of
    Aziz MA; Akter T; Islam MS
    Technol Cancer Res Treat; 2022; 21():15330338221109798. PubMed ID: 35770306
    [No Abstract]   [Full Text] [Related]  

  • 18. Hsa-miR-196a2 functional SNP is associated with the risk of ESCC in individuals under 60 years old.
    Wang N; Li Y; Zhou RM; Wang GY; Wang CM; Chen ZF; Liu W
    Biomarkers; 2014 Feb; 19(1):43-8. PubMed ID: 24320161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility.
    Du W; Ma XL; Zhao C; Liu T; Du YL; Kong WQ; Wei BL; Yu JY; Li YY; Huang JW; Li ZK; Liu L
    Asian Pac J Cancer Prev; 2014; 15(2):1047-55. PubMed ID: 24568449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations in microRNAs and the risk and survival of renal cell cancer.
    Du M; Lu D; Wang Q; Chu H; Tong N; Pan X; Qin C; Yin C; Wang M; Zhang Z
    Carcinogenesis; 2014 Jul; 35(7):1629-35. PubMed ID: 24681820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.